Abstract:The purpose of this study was to test whether the insulin sensitivity, lipid metabolism and the susceptibility of the heart to ischemia/reperfusion injury are modulated by the chronic estrogen status. Rats were ovariectomized (OVX), not ovariectomized (sham) or ovariectomized and treated with subcutaneous 17 -estradiol (30 mug/kg/day, OVX+E2) (n=14-17 per group). Within 3 months after operation, body weight, the serum levels of estrogen, glucose, insulin, total cholesterol (T-chol), HDL-chol, LDL-cholesterol (LDL-chol), triglycerides (TG) and lipoprotein a (Lp(a)) were monitored. Three months after operation, hearts of partial rats (n=6-8 per group) were isolated and allowed an initial 20-min stabilization period, and then cardiac function was recorded and creatine kinase (CK) release in the coronary effluent was measured after 4 h of hypothermic ischemia in isolated rat hearts. The experimental results showed that from 2 weeks after ovariectomy to the end of the study, body weights of OVX were significantly higher compared with the other two groups (p<0.05). On weeks 5 and 9, insulin level of OVX was significantly higher than that of the other two groups (p<0.05), whereas it was not different among the three groups on weeks 12 and 13 (p>0.05). Blood glucose on week 13 was significantly higher in OVX (p<0.05). Consequently, Insulin Sensitivity Index (ISI) of OVX was lower than that of the other two groups on weeks 5 and 9 (p<0.05), but not on weeks 12 and 13. Serum values for T-chol, HDL-chol and LDL-chol were not significantly different among the three groups within the observing period. On week 13, TG level in ovariectomized group was significantly lower than in the sham- and E2-treated groups (p<0.05). Compared with sham, Lp(a) level was slight increased in OVX rats (p<0.05), while it was further increased in E2-treated rats (p<0.05). Cardiac function (left ventricular pressure (LVP) and +/-dp/dtmax) of hearts removed from OVX rats was depressed, and CK release was markedly increased (p<0.05). However, treatment with E2 significantly improved cardiac function, as shown by increasing left ventricular pressure,+dp/dtmax and -dp/dtmax, and decreased CK release. In conclusion, chronic E2 treatment has some beneficial effects on cardiovascular disease (CVD), which come from the results of improvement of insulin sensitivity and post-ischemia cardiac function. However, the mechanism did not include changes in lipids and lipoproteins. The change in Lp(a) level shows that estrogen does not confer cardiovascular protection and may increase the risk of stroke.

Oestradiol Supplement Minimises Coronary Occlusion-Induced Myocardial Infarction and Ventricular Dysfunction in Oophorectomised Female Rats.

Estrogen therapy, independent of timing, improves cardiac structure and function in oophorectomized mRen2.Lewis rats

17β-Oestradiol facilitates M2 macrophage skewing and ameliorates arrhythmias in ovariectomized female infarcted rats

17SS-Estradiol Antagonizes the Down-Regulation of ERα/NOS-3 Signaling in Vascular Endothelial Dysfunction of Female Diabetic Rats.

Influence of Ovariectomy and 17Β-Estradiol Treatment on Insulin Sensitivity, Lipid Metabolism and Post-Ischemic Cardiac Function

Treatment with oestrogen-receptor agonists or oxytocin in conjunction with exercise protects against myocardial infarction in ovariectomized rats

Early Estrogen Replacement Therapy Attenuates Cardiac Dysfunction Caused by Aging and Ovariectomy in Female Wistar Rats

[Effects of Estradiol Intervention on Peripheral Blood CD90+ Cells and Cardiac Function in De-Ovary Rats Before and after Myocardial Infarction].

Effect of estrogen replacement treatment on ischemic preconditioning in isolated rat hearts.

Suppression of High Bone Remodelling by E'Jiao in Ovariectomised Rats.

The protective effect of Er-Xian decoction against myocardial injury in menopausal rat model

17-Β Estradiol Attenuates Ovariectomy-Induced Changes in Cardiomyocyte Contractile Function Via Activation of AMP-activated Protein Kinase.

Estrogen-replacement Therapy Promotes Angiogenesis after Acute Myocardial Infarction by Enhancing SDF-1 and Estrogen Receptor Expression.

Abstract 14875: Estrogen-Induced Vasoprotection is Preserved after Prolonged Estrogen Deprivation

Dynamic Oxidative Stress and DNA Damage Induced by Oestrogen Deficiency and Protective Effects of Puerarin and 17β‐oestradiol in Ovariectomized Rats

The Loss of Estrogen Efficacy Against Cerebral Ischemia in Aged Postmenopausal Female Mice

Effects of estrogen on peripheral blood stem cells and angiogenesis in myocardial infarction rats

Impact of Estrogen Replacement on Ventricular Myocyte Contractile Function and Protein Kinase B/Akt Activation.

[Estradiol Promote Myocardial Angiogenesis in a Rat Model of Acute Myocardial Infarction Through Estrogen Receptors].

Puerarin ameliorated pressure overload-induced cardiac hypertrophy in ovariectomized rats through activation of the PPARα/PGC-1 pathway

16α-OHE1, a novel oestrogen metabolite, attenuates dysfunction of left ventricle contractility via regulation of autophagy after myocardial ischemia and reperfusion